SOUTH
SAN FRANCISCO, Calif., May 30, 2023
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a
precision medicine oncology company committed to the discovery and
development of targeted therapeutics, announced its participation
in upcoming investor relations events.
Barclays Lunchtime Biotech Fireside Chat Series
Thursday, June 1st, 2023
at 12:00 PM ET
- Fireside chat with Yujiro S.
Hata, Chief Executive Officer, hosted by Peter Lawson, D.Phil. Managing Director, Equity
Research Analyst
2023 Jefferies Global Healthcare Conference
Wednesday, June 7th, 2023
at 12:30 PM ET
- Fireside chat with Yujiro S.
Hata, Chief Executive Officer, hosted by Maury Raycroft, Ph.D. Equity Research Analyst,
Biotechnology
Goldman Sachs 44th Annual Global Healthcare Conference
Thursday, June 15th, 2023
at 1:40 PM ET
- Fireside chat with Yujiro S.
Hata, Chief Executive Officer, hosted by Corinne Jenkins, Vice President, Equity
Research, Biotechnology
A live audio webcast of conference events, as permitted by
conference host, will be available at the "Investors/News and
Events/Investor Calendar" section of the IDEAYA website at
https://ir.ideayabio.com/events and/or through the conference
host. A replay of available webcasts will be accessible for
30 days following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the
discovery and development of targeted therapeutics for patient
populations selected using molecular diagnostics. IDEAYA's
approach integrates capabilities in identifying and validating
translational biomarkers with drug discovery to select patient
populations most likely to benefit from its targeted
therapies. IDEAYA is applying its early research and drug
discovery capabilities to synthetic lethality – which represents an
emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to participation
in and/or presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's recent
Quarterly Report on Form 10-Q filed on May
9, 2023 and any current and periodic reports filed with the
U.S. Securities and Exchange Commission.
Investor and Media Contact
IDEAYA Biosciences
Paul Stone
Chief Financial Officer
investor@ideayabio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-june-2023-investor-relations-events-301836732.html
SOURCE IDEAYA Biosciences, Inc.